Erratum: A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

<p>Cognitive impairment in depression: recent advances and novel treatments</p>

Perini, G., Cotta Ramusino, M., Sinforiani, E., Bernini, S., Petrachi, R., & Costa, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199746 · Cited by 384 · see citing works

Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment

Fagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127 · see citing works

Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial

McIntyre, R. S., Phan, L., Kwan, A. T. H., Mansur, R. B., Rosenblat, J. D., Guo, Z., Le, G. H., Lui, L. M. W., Teopiz, K. M., Ceban, F., et al. (2023) · Brain · doi:10.1093/brain/awad377 · Cited by 45 · see citing works

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Nishimura, A., Aritomi, Y., Sasai, K., Kitagawa, T., & Mahableshwarkar, A. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12565 · Cited by 45 · see citing works

Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm

Spurny‐Dworak, B., Vanicek, T., Seiger, R., Reed, M. B., Klöbl, M., Ritter, V., Unterholzner, J., Godbersen, G. M., Silberbauer, L., Pacher, D., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117913 · Cited by 35 · see citing works

Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT3 receptors

López-Sánchez, U., Munro, L. J., Ladefoged, L. K., Pedersen, A. J., Brun, C. C., Lyngby, S. M., Baud, D., Juillan‐Binard, C., Pedersen, M. G., Lummis, S. C. R., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01282-x · Cited by 17 · see citing works

Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism

Felice, D., Guilloux, J., Pehrson, A. L., Li, Y., Mendez‐David, I., Gardier, A. M., Sánchez, C., & David, D. J. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00204 · Cited by 12 · see citing works

The effectiveness of vortioxetine on neurobiochemical metabolites and cognitive of major depressive disorders patients: A 8-week follow-up study

Zhang, Y., Lai, S., Zhang, J., Wang, Y., Zhao, H., He, J., Huang, D., Chen, G., Qi, Z., Chen, P., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.272 · Cited by 11 · see citing works

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial

Ostuzzi, G., Gastaldon, C., Barbato, A., D’Avanzo, B., Tettamanti, M., Monti, I., Aguglia, A., Aguglia, E., Alessi, M. C., Amore, M., et al. (2020) · Trials · doi:10.1186/s13063-020-04460-6 · Cited by 11 · see citing works

Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome

Christensen, M. C., & Munro, V. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1416952 · Cited by 9 · see citing works

Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program

Lawrence, D. F. E., Manjelievskaia, J., Chrones, L., McCue, M., & Touya, M. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1918072 · Cited by 7 · see citing works

Cognitive Deficits in Major Depression

Coles, A. S., Lee, Y.-N., Subramaniapillai, M., & McIntyre, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00004-5 · Cited by 2 · see citing works

A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality

Ye, X., Xu, P., Jiao, J., Zhao, H., Jin, K., Zhang, S., Pan, F., Chen, J., Jiang, H., Hu, J., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s491768 · Cited by 3 · see citing works

Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients

Filippova, N. V., Barylnik, Y. B., Богданова, Т. М., Blinova, V. V., Shchelchkova, A. A., & Mozgacheva, E. S. (2023) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2023-817 · Cited by 3 · see citing works

An Environment-Wide Study of Adult Cognitive Performance in the 23andMe CohortPreprint

Huang, Y., Filshtein, T. J., Gentleman, R. C., & Aslibekyan, S. W. (2019) · medRxiv · doi:10.1101/19009076

The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications

Prelog, P. R., Plesničar, B. K., Zupan, M., Frol, S., & Kramberger, M. G. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2653170

Vortioxetine Improves Cognitive Function, Lessens Symptoms of Major Depression

Hoyle, B. D., & McIntyre, R. S. (2014) · MD Conference Express · doi:10.1177/155989771408005

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.52 · Cited by 307 · see citing works

Randomized, double-blind, placebo-controlled study of the efficacy of vortioxetine on cognitive dysfunction in adult patients with major depressive disorder (MDD)

McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2013) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 3 · see citing works

Efficacy of Vortioxetine in the Treatment of Cognitive Symptoms of Major Depressive Disorder

Guillena, S. L. R. (2018) · doi:10.26226/morressier.5a7070e6d462b80290b56e40

An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-referenced (Paroxetine), Fixed-dose Study on the Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Lundbeck (2020) · Vivli · doi:10.25934/00005850